miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia
Open Access
- 26 April 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 7 (1), 11452
- https://doi.org/10.1038/ncomms11452
Abstract
MicroRNAs are subject to precise regulation and have key roles in tumorigenesis. In contrast to the oncogenic role of miR-22 reported in myelodysplastic syndrome (MDS) and breast cancer, here we show that miR-22 is an essential anti-tumour gatekeeper in de novo acute myeloid leukaemia (AML) where it is significantly downregulated. Forced expression of miR-22 significantly suppresses leukaemic cell viability and growth in vitro, and substantially inhibits leukaemia development and maintenance in vivo. Mechanistically, miR-22 targets multiple oncogenes, including CRTC1, FLT3 and MYCBP, and thus represses the CREB and MYC pathways. The downregulation of miR-22 in AML is caused by TET1/GFI1/EZH2/SIN3A-mediated epigenetic repression and/or DNA copy-number loss. Furthermore, nanoparticles carrying miR-22 oligos significantly inhibit leukaemia progression in vivo. Together, our study uncovers a TET1/GFI1/EZH2/SIN3A/miR-22/CREB-MYC signalling circuit and thereby provides insights into epigenetic/genetic mechanisms underlying the pathogenesis of AML, and also highlights the clinical potential of miR-22-based AML therapy.Keywords
This publication has 70 references indexed in Scilit:
- Tet and TDG Mediate DNA Demethylation Essential for Mesenchymal-to-Epithelial Transition in Somatic Cell ReprogrammingCell Stem Cell, 2014
- SnapShot: Acute Myeloid LeukemiaCancer Cell, 2012
- Epigenetic Therapies in MDS and AMLAdvances in experimental medicine and biology, 2012
- Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid LeukemiaHematology/Oncology Clinics of North America, 2011
- Genetics of Myelodysplastic Syndromes: New InsightsHematology-American Society Hematology Education Program, 2011
- TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelityNature, 2011
- Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cellsNature, 2011
- Leukaemogenesis: more than mutant genesNature Reviews Cancer, 2010
- MDS and secondary AML display unique patterns and abundance of aberrant DNA methylationBlood, 2009
- Acute myeloid leukaemiaThe Lancet, 2006